Kadiant Partners with Central Valley Autism Project

Kadiant, a mission-driven organization that provides high-quality
Applied Behavior Analysis (ABA) therapy and related services to
individuals diagnosed with autism spectrum disorder (ASD), announced
today it has partnered with Central Valley Autism Project (CVAP), a
pioneer provider of ABA services in both center and home-based settings.
Kadiant’s partnership with CVAP marks the company’s third, following its
investment in Kids Overcoming (KOI) and pending investment in Integrated
Behavioral Solutions (IBS). Terms of the partnerships are not being
disclosed.

Founded in 1990 by Mila Amerine Dickens in Modesto, California, CVAP
originally established its excellent clinical reputation as a
replication site for Dr. Ivar Lovaas’ early research into the efficacy
of ABA for individuals with autism. Since then, Amerine Dickens and her
team have partnered with schools, California regional centers, academic
institutions, and other advocates to build capacity in significantly
underserved communities.

“When I started working with kids over 30 years ago, I did not intend to
be a business owner,” said Amerine Dickens. “However, at the time Dr.
Lovaas’s seminal 1987 study was becoming more public, autism was on the
rise, and I was compelled to carry forward his work to help children in
our community with autism. As I look back, our community, schools, and
regional centers worked together to do something groundbreaking for the
ABA field that was presented at numerous conferences and published in
large-scale research articles. For the past few years, I’ve contemplated
the future of CVAP, and Kadiant is a perfect fit to carry forward our
mission.”

“CVAP, and Mila specifically, are pioneers in the development of autism
services. Over the years, the CVAP team has contributed to the evidence
base of ABA intervention effectiveness, and it has successfully
partnered with all stakeholders across Central Valley’s communities to
build capacity where none existed. Kadiant is honored to carry forward
this incredible legacy,” said Lani Fritts, CEO of Kadiant.

Amerine Dickens will continue as an advisor to Kadiant. The CVAP team
will work closely with KOI and IBS to share best practices and integrate
operations and services across the Kadiant organization.

About Kadiant

Established in 2019 as a partnership between Lani Fritts, TPG Capital
and Vida Ventures, Kadiant is a mission-driven company that seeks to
provide high-quality Applied Behavior Analysis (ABA) therapy and related
critical services to individuals diagnosed with autism spectrum disorder
(ASD). Kadiant focuses on building excellent clinical teams and
expanding access to services by acquiring and integrating existing
high-quality providers and opening new locations as part of a strategy
to build a leading autism services organization. Kadiant is committed to
delivering the best clinical outcomes and the best client experience.
For more information, visit https://kadiant.com/.

About CVAP

Central Valley Autism Project was founded in 1990 in the central valley
of California. The company partners with schools, regional centers, and
health plans in Sacramento, Stockton, Modesto, Fresno and the
surrounding communities. CVAP’s clinical teams serve individuals of all
ages with autism and other developmental disabilities and specialize in
comprehensive Early Intensive Behavioral Intervention (EIBI), social
skills development, and parent inclusion education. The company provides
services in company-operated clinics, homes, schools and community
settings. For more information, visit www.CVAP.org.

About TPG

TPG is a leading global alternative asset firm founded in 1992 with more
than $104 billion of assets under management and offices in Austin,
Beijing, Boston, Dallas, Fort Worth, Hong Kong, Houston, London,
Luxembourg, Melbourne, Moscow, Mumbai, New York, San Francisco, Seoul,
and Singapore. TPG’s investment platforms are across a wide range of
asset classes, including private equity, growth venture, real estate,
credit, and public equity. TPG aims to build dynamic products and
options for its investors while also instituting discipline and
operational excellence across the investment strategy and performance of
its portfolio. For more information, visit www.tpg.com.

About Vida Ventures

Vida Ventures is a next-generation life sciences investment firm founded
in 2017 by a group of scientists, physicians, entrepreneurs and
investors passionate about building and funding breakthroughs in
biomedicine. Together they form an independent, bold investment group
bound together by a simple word – life. Its mission is to bring science
to life and advance transformative biomedical innovations that have the
potential to make a meaningful difference for patients. Vida has a
bicoastal presence and currently manages approximately $355 million. For
more information on Vida Ventures, please visit www.vidaventures.com,
on LinkedIn or follow on Twitter @Vida_Ventures.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190515005526/en/